ASNS and leukemia: Normal cells, equipped with asparagine synthetase, can synthesize L-asparagine, whereas leukemia cells, deficient in asparagine synthetase, are unable to synthesize sufficient L-asparagine, leading to impaired protein synthesis and subsequent anti-tumor effects (62).